Points of Pride

Latest News

Third Rock Ventures launches Fulcrum Therapeutics

Michael Green of UMMS a co-founder Mission to unlock gene control mechanisms, develop small molecule therapies for disease. 

 

SPINRAZA™ (nusinersen)  

Approved in U.S. to Treat Broad Range of Patients with Spinal Muscular Atrophy.

  

FDA Approves Merck's ZINPLAVA

Reduce Recurrence of Clostridium difficile Infection in Adult Patients Receiving Antibacterial Drug Treatment.

   

 


 

Office of Technology Management Statistics  

Average per year for the past 10 years. 

 

Revenue  

  

Licensing Revenue

Out of 155 U.S. 

Universities in licensing revenue

 

in NIH funds 

Among New England Medical Schools 

 


 

 Innovation 

  

Invention Disclosures

Patent Applications

 

Patents Issued 

 


  

Business 

 

CDAs

MTAs

Deals Done 

▴ Back To Top
Section Menu To Top